YouScript adds thought leaders in healthcare innovation, precision medicine, informatics, and patient safety (Seattle, WA) March 7, 2018 – YouScript today announced the addition of Russel Altman, MD, PhD, Christine…
Read More
At any given moment, clinicians have access to a variety of resources designed to make their job more efficient. These resources range from static clinical references to fully actionable, dynamic,…
Read More
What Makes the Best Decision Support Tools So Widely Utilized? Health care providers need access to up-to-date and clinically-actionable clinical decision support tools throughout the care continuum. To satisfy this…
Read More
Grane Rx is poised to take a leading role in promoting patient safety through precision medicine. YouScript and Grane Rx announce today an agreement to deliver precision prescribing support to…
Read More
YouScript and PDX announce today an agreement to deliver integrated YouScript® precision prescribing clinical decision support to all PDX pharmacy software users that opt in. Pharmacists will now be able…
Read More
YouScript, a life-saving clinical decision support tool, aiding enterprise health solution providers in reducing the adverse drug event epidemic. Seattle, WA — (July 26, 2017) — YouScript is now a…
Read More
Disruptive innovation refers to an innovation that creates a new market and value network and eventually disrupts an existing market and value network, displacing established market leading firms, products, and…
Read More
YouScript CEO Kristine Ashcraft attended the Long Term Post Acute Care & HIT Summit this week in Baltimore, MD to present a talk on the implications of pharmacogenetic testing, polypharmacy,…
Read More
Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field. While you can go and search out the news yourself, we…
Read More
We had a fantastic time in sunny, warm, Orlando, FL last week at HIMSS 2017! The YouScript team made amazing connections, met some friends, made new ones, and continued to…
